Search results
Results from the WOW.Com Content Network
Education in Sri Lanka has a long history that dates back two millennia. While the Constitution of Sri Lanka does not provide free education as a fundamental right, the constitution mentions that 'the complete eradication of illiteracy and the assurance to all persons of the right to universal and equal access to education at all levels" in its section on directive principles of state policy ...
Sri Lankan English (SLE) is the English language as it is used in Sri Lanka, a term dating from 1972. [1] Sri Lankan English is principally categorised as the Standard Variety and the Nonstandard Variety, which is called as "Not Pot English". The classification of SLE as a separate dialect of English is controversial.
In October 2016 Nazeri was appointed as a director of Novo Nordisk [2] [3] and worked to build partnerships and drive innovation. [4] Nazeri has expressed concern about the lack of awareness around the health risks of diabetes mellitus type 2, especially with regards to the development of cardiovascular disease. [5]
The new trial looked at liraglutide, the active ingredient used in two of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a diabetes drug.
The Sri Lankan Ordinary Level (O-level) formerly called Senior School Certificate (SSC), is a General Certificate of Education (GCE) qualification in Sri Lanka, conducted by the Department of Examinations of the Ministry of Education. It is based on the Cambridge University Ordinary Level qualification.
The Department of Examinations is a non-ministerial government department of Sri Lanka and the national examination service. It comes within the purview of the Ministry of Education . The department is responsible for carrying out public examinations such as the General Certificate of Education Ordinary Level (SL) and Advanced Level and other ...
Research sponsored by Novo Nordisk in patients with type 2 diabetes found that, together with diet and exercise, Ozempic led to an average weight loss of almost 10 pounds, while Rybelsus led to an ...
NNC9204-1706 or NN9423 is a GLP-1/GIP/glucagon receptor triple agonist developed by Novo Nordisk. [1] [2] It was evaluated in a clinical trial; [3] [4] adverse effects such as "dose-dependent increases in heart rate and reductions in reticulocyte count, increases in markers of inflammation and hepatic disturbances, and impaired glucose tolerance at the highest dosages" meant that the drug was ...